Sat, Sep 20, 2014, 9:55 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • blackoutbuzz blackoutbuzz Mar 26, 2013 12:09 AM Flag

    Another addition to the pipeline for $160M

    Steady rate of acquisitions to enable future growth

    -----------------------
    Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ophthalmology therapeutic category and brings a new phase 3 compound - LIFITEGRAST - currently under development for the signs and symptoms of dry eye disease, into Shire's portfolio. Shire anticipates launching LIFITEGRAST in the United States as early as 2016 pending a positive outcome of the phase 3 clinical development program and regulatory approvals. Shire is acquiring the global rights to LIFITEGRAST and will evaluate an appropriate regulatory filing strategy for markets outside of the United States.

 
SHPG
258.17-2.33(-0.89%)Sep 19 4:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.